Directory Image
This website uses cookies to improve user experience. By using our website you consent to all cookies in accordance with our Privacy Policy.

Protein A Resins Market to reach $900mn by 2024

Author: Juee Kate
by Juee Kate
Posted: May 03, 2017

  • The global report "Protein A Resins Market Size By Application (Immunoprecipitation, Antibody Purification), By Product (Natural protein A, Recombinant Protein A), By Matrix (Agarose, Glass/Silica Gel, Organic Polymer), By End Use (Biopharmaceutical, Clinical Research, Academic Research, CRO), Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, UK, Spain, Italy, Russia, Poland, Japan, China, India, Australia, Argentina, Brazil, Mexico, South Africa, UAE, Saudi Arabia, Qatar, Kuwait, Egypt), Growth Potential, Price Trends, Competitive Market Share & Forecast, 2016 – 2024" by Global Market Insights, Inc. says Protein A Resin Market size is slated to surpass USD 900 million by 2024.

Protein A resin market is witnessing an inflection point with the increasing research on biotechnological sector for novel drug development. Growing prevalence of chronic diseases like rheumatoid arthritis, cancer, etc., and the extensive use of monoclonal antibodies in these treatments, is growing at an appreciable pace. In addition to this, recent revolution in protein separation and purification techniques which include chromatography, precipitation, and filtration, is also expected to drive Protein A resin industry globally.

Request for a sample of this research report @ https://www.fractovia.org/request-sample/329

In depth analysis of the market based on applications, products, regions, and end users:

Protein A resin industry mainly finds its application in two areas- antibody purification, and immunoprecipitation. Protein A resin market size in antibody purification is slated to witness a substantial growth in future, with an expected revenue share of USD 700 million by 2024, driven by the increasing diagnostic application of recombinant and monoclonal antibodies. In this regard, India has witnessed a remarkable growth owing to the surging rate of cancer patients in this region. Immunoprecipitation applications held a share of 20% of the Protein A resin industry, and is anticipated to grow an annual rate of 8% over the period 2016- 2024.

Based on the product trends, recombinant Protein A resin market is forecast to outsell natural Protein A resin industry with a projected annual growth rate of 8.3% of the former over 2016-2024.

Browse key industry insights spread across 127 pages with 123 market data tables & around 8 figures & charts from this 2017 report Protein A Resins Market in detail along with the table of contents at:

https://www.fractovia.org/news/industry-research-report/protein-a-resins-market

Geographically, U.S. Protein A resin industry covered 85% of the total share in 2015 and is expected to continue its regional dominance due to the dynamically increasing healthcare infrastructure related to clinical practices. Asia Pacific market is also anticipated to show a striking annual growth rate of 8.5% over the coming seven years with a major contribution of Japan as it accounted for almost 40% of the total share in 2015, Japan protein A resin industry will exceed a revenue worth 78 million by 2024. Another niche region with a strong growth prospect is Spain, owing to the country’s demand for biosimilar products.

Biopharmaceutical farms and Contract research organizations are the two major end users of Protein A resin industry. Biopharmaceutical industries accounted for a share of 75% of Protein A resin market in 2015, and is expected to surpass USD 680 million by 2024. CROs accounted for the second highest revenue share in 2015 and is estimated to record USD 130 million with an annual growth rate of 8.1% over the coming seven years.

Make an inquiry for purchasing this report @https://www.fractovia.org/request-purchase/329

Geographic expansion, strategic acquisitions, agreements, and continuous effort to enhance the product portfolio are the major strategies adopted by the market players to sustain the competitive market.

Prominent industry players include GE Healthcare, GenScript, Repligen, and Merck Millipore (EMD Millipore).

About Fractovia.org:

Fractovia.org is one of India's leading in-house and free news portal. It is fully automated, and operates on a constant premise, interfacing with news sites and offering redesigned breaking features to readers across the globe. Our mission is to offer individuals opportunities for connections with news writers and distributors which they can pursue. We operate by mapping articles pertaining to breaking news, constantly and progressively, against a pre-determined word-based theme, offering important connections to readers and clients, as well as distributors.

Contact Us:

Arun HegdeCorporate Sales, USA

Fractovia.orgPhone: 1-302-846-7766

  • Email: sales@fractovia.org
  • Web:https://www.fractovia.org
  • Contact Us:
Facebook | Twitter

About the Author

Fractovia.org is one of India's leading in-house and free news portal. It is fully automated, and operates on a constant premise, interfacing with news sites and offering redesigned breaking features to readers across the globe.

Rate this Article
Leave a Comment
Author Thumbnail
I Agree:
Comment 
Pictures
Author: Juee Kate

Juee Kate

Member since: Jan 15, 2017
Published articles: 76

Related Articles